New Haven, CT · Founded 2018 · Privately Held (backing)
Developer of a therapeutic drug designed to reverse neurodegeneration. Allyx Therapeutics is based in New Haven, CT and was founded in 2018. Its last reported valuation was $32.3 million in Feb 2023. It has raised $13.2 million across 4 recorded rounds; the latest was a $26.4 million early-stage round in May 2026.
Last reported valuation
$32.3M
Oct 2026
Priced at
—
Total raised
$13.2M
Last round
Early Stage VC
May 2026
No prints on record
No secondary trades in Allyx Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Allyx Therapeutics with a free account
·Watch Allyx Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Allyx Therapeutics stock.
